According to Taiwan media reports on August 24, Taiwan’s self-produced high-end vaccine (6547) reported its first vaccination death case today (24). As soon as the news came out at noon, the stock price of in ’s late trading immediately fell sharply, plummeting 33 yuan (NTD, the same below), and finally closed at 303.5 yuan, a drop of 9.79%, approaching ’s limit-down ; high-end vaccine parent company Chia ( 3176) was also affected by this news, and fell slightly by 1.6 yuan in late trading to close at 60.9 yuan, a drop of 2.56%.
It is reported that a columnist surnamed Lu died yesterday (23) after receiving a high-end vaccine in Taoyuan, Taiwan. "Taiwan Epidemic Command Center Commander" Chen Shizhong said that at present, it is initially understood that it may be a myocardial infarction, but it needs to be verified by the judiciary.
It is understood that the columnist just went to get a high-end vaccine with his family yesterday, but at around 9:00 this morning, he suddenly developed symptoms of discomfort. However, whether it is related to the high-end vaccine needs further investigation.
